Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...
Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...
There’s a difference between returning and simply repeating. Repetition is mechanical—doing the same thing expecting the same ...
Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...
The article 🌱 Patch AM: 2 Hospitalized, Road Closed After Head-On Crash In Branford: Police appeared first on Branford Patch ...
David Mitchell spent a career in labor and political advocacy before a cancer diagnosis made him an advocate for patients ...
Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery ...
T-cell engagers (TCEs) have the most promising product profile across all deep B-cell depleting modalitiesCizutamig (BCMA TCE) positioned as first and best-in-class for autoimmune diseasesOver 60 ...
The Voice features host Gloria Burns in a meaningful conversation with Roxie Soto from the Leukemia & Lymphoma Society (LLS) to highlight the organization’s mission, patient support programs, ...
San Carlos, California Thursday, January 8, 2026, 13:00 Hrs [IST] ...
Bucks Herald on MSN
Major facelift for cancer unit facilities
Work has been completed on a major refurbishment project at the Cancer Care and Haematology Unit (CCHU), Stoke Mandeville ...
Analyses of mpox clades currently in circulation provide clues to how the virus managed to spread worldwide in 2022 — and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback